PreprintCited by 840Cancer, Hypoxia, and MetabolismPI3K/AKT/mTOR signaling in cancerAngiogenesis and VEGF in Cancer

Loss of PTEN facilitates HIF-1-mediated gene expression

Open access
Zundel, Wayne, Schindler, Cornelia, Haas-Kogan, Daphne, Koong, Albert, Kaper, Fiona, Chen, Eunice, Gottschalk, Alexander R., Ryan, Heather E. +4 more·2000·Genes & Development

Abstract

In glioblastoma-derived cell lines, PTEN does not significantly alter apoptotic sensitivity or cause complete inhibition of DNA synthesis. However, in these cell lines PTEN regulates hypoxia- and IGF-1-induced angiogenic gene expression by regulating Akt activation of HIF-1 activity. Restoration of wild-type PTEN to glioblastoma cell lines lacking functional PTEN ablates hypoxia and IGF-1 induction of HIF-1-regulated genes. In addition, Akt activation leads to HIF-1alpha stabilization, whereas PTEN attenuates hypoxia-mediated HIF-1alpha stabilization. We propose that loss of PTEN during malignant progression contributes to tumor expansion through the deregulation of Akt activity and HIF-1-regulated gene expression.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/gad.14.4.391

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Inactivating mutations in PTEN or TSC, as well as activating mutations in PI3K or AKT, lead to increased TORC1 activity that promotes HIF-α stabilization.

    “Inactivating mutations in phosphatase and tensin homolog (PTEN) or the tuberosis sclerosis complex (TSC) complex, as well as activating mutations in phosphatidylinositol 3-kinase (PI3K) or AKT, lead to increased TORC1 activity that promotes HIF-α stabilization”

    From Hypoxic control of metastasis (2016) · cites this paper as [31]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 40 · Cited by 840

Authors
Zundel, W., Schindler, C., Haas-Kogan, D., Koong, A., Kaper, F., Chen, E., Gottschalk, A. R., Ryan, H. E., Johnson, R. S., Jefferson, A. B., Stokoe, D., & Giaccia, A. J.
Affiliations
University of California, San Francisco (US)
Venue
Genes & Development
Published
2000-02-15
Volume
14
Issue
4
Pages
391-396
ISSN
  • 0890-9369 (ISSN-L)
  • 1549-5477
OpenAlex
W2129873928
Cited by
840
References
40
Citations by year
2026: 6 · 2025: 11 · 2024: 13 · 2023: 13 · 2022: 9 · 2021: 14 · 2020: 13 · 2019: 20 · 2018: 10 · 2017: 23 · 2016: 24 · 2015: 27 · 2014: 35 · 2013: 38 · 2012: 33
Type
posted content
Language
en
Open access
Locations
  • Genes & Development (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Radiological Society of North America
  • National Institutes of Health (5r01ca073832-02, CA67166)
  • National Cancer Institute (P01CA067166, CA09302, CA 67166, CA 73832, T32CA009302)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
Keywords
PTEN, HIF-1, glioblastoma, Akt signaling, HIF-1α stabilization, hypoxia, insulin-like growth factor I, angiogenesis, tumor angiogenesis, tumor progression, tumor suppressor loss
MeSH terms
Brain Neoplasms, DNA-Binding Proteins, Genetic Complementation Test, Glioblastoma, Humans, Insulin-Like Growth Factor I, Isoenzymes, Lymphokines, Membrane Proteins, Neoplasm Proteins, Nuclear Proteins, Phosphofructokinase-1, Phosphoric Monoester Hydrolases, Prostaglandin-Endoperoxide Synthases, Proto-Oncogene Proteins, Recombinant Fusion Proteins, Transcription Factors, Transfection, Tumor Cells, Cultured, Cell Hypoxia, Gene Expression Regulation, Neoplastic, Endothelial Growth Factors, Culture Media, Serum-Free, Apoptosis, Protein Serine-Threonine Kinases, Gene Deletion, Phosphotransferases (Alcohol Group Acceptor), Disease Progression, Tumor Suppressor Proteins, Vascular Endothelial Growth Factors, Vascular Endothelial Growth Factor A, Proto-Oncogene Proteins c-akt, PTEN Phosphohydrolase, Cyclooxygenase 1, Hypoxia-Inducible Factor 1, Hypoxia-Inducible Factor 1, alpha Subunit

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review